Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: A prospective study

Pancreatology

Volumn 11, Issue 6, 2011, Pages 535-545

  Halloran, Christopher M ^a   Cox, Trevor F ^a,b   Chauhan, Seema ^a   Raraty, Michael G T ^a   Sutton, Robert ^a   Neoptolemos, John P ^a   Ghaneh, Paula ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Coefficient of fat absorption; FE 1 and QoL; Pancreatic cancer; Pancreatic exocrine insufficiency; Surgery

Indexed keywords

FECES LIPID; PANCREATIC ELASTASE;

ADULT; AGED; APPETITE; ARTICLE; BODY MASS; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME BLOOD LEVEL; FECES ANALYSIS; FEMALE; HUMAN; INSOMNIA; LIPID ABSORPTION; MALE; PANCREAS CANCER; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS RESECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SOCIAL INTERACTION;

EID: 81155144602     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000333308     Document Type: Article

References (38)

1. Alexakis N, Halloran C, Raraty M, et al: Current standards of surgery for pancreatic cancer. Br J Surg 2004; 91: 1410-1427. (Pubitemid 39518076)
2. Birkmeyer JD, Stukel TA, Siewers AE, et al: Surgeon volume and operative mortality in the United States. N Engl J Med 2003; 349: 2117-2127. (Pubitemid 37464537)
3. Neoptolemos JP, Stocken DD, Friess H, et al: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-1210. (Pubitemid 38339364)
4. Neoptolemos JP, Stocken DD, Ghaneh P, et al: ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. J Clin Oncol 2009; 27: 18s:supp, abstr LBA4505.
5. Neoptolemos JP, Stocken DD, Bassi C, et al: Adjuvant chemotherapy with fluorouracil plus folinic acid vs. gemcitabine following pancreatic cancer resection: A randomized controlled trial. JAMA 2010; 304: 1073-1081.
6. Rosemurgy A, Cowgill S, Coe B, et al: Frequency with which surgeons undertake pancreaticoduodenectomy continues to determine length of stay, hospital charges, and inhospital mortality. J Gastrointest Surg 2008; 12: 442-449.
7. Diener MK, Seiler CM, Rossion I, et al: Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): A randomised, controlled multicentre trial. Lancet 2011; 377: 1514-1522.
8. Armstrong T, Walters E, Varshney S, et al: Deficiencies of micronutrients, altered bowel function and quality of life during late follow-up after pancreatoduodenectomy for malignancy. Pancreatology 2002; 2: 528-534. (Pubitemid 35365341)
9. Tran TC, van Lanschot JJB, Bruno M, et al: Functional changes after pancreatoduodenectomy. Pancreatology 2009; 9: 729-737.
10. DiMagno EP, Go VL, Summerskill WH: Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973; 288: 813-815.
11. Keller J, Aghdassi AA, Lerch MM, et al: Tests of pancreatic exocrine function -clinical significance in pancreatic and non-pancreatic disorders. Best Pract Res Clin Gastroenterol 2009; 23: 425-439.
12. Keller J, Layer P: Human pancreatic exocrine response to nutrients in health and disease. Gut 2005; 54:vi1-vi28. (Pubitemid 40868314)
13. Matsumoto J, Traverso LW: Exocrine function following the Whipple operation as assessed by stool elastase. J Gastrointest Surg 2006; 10: 1225-1229. (Pubitemid 44750741)
14. Neoptolemos JP, Ghaneh P, Andren-Sandberg A, et al: Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs. standard dose pancreatin. Int J Pancreatol 1999; 25: 171-180. (Pubitemid 29379959)
15. Nordback I, Parvianen M, Piironen A, et al: Obstructed pancreaticojejunostomy partly explains exocrine insufficiency after pancreatic head resection. Scand J Gastroenterol 2007; 42: 263-270.
16. Tran TCK, van't Hof G, Hazemier G, et al: Pancreatic fibrosis correlates with exocrine pancreatic insufficiency after pancreatoduodenectomy. Dig Surg 2008; 25: 311-318.
17. Müller MW, Friess H, Martin DJ, et al: Longterm follow-up of a randomized clinical trial comparing Beger with pylorus-preserving Whipple procedure for chronic pancreatitis. Br J Surg 2008; 95: 350-356.
18. Fang WL, Su CH, Shyr YM, et al: Functional and morphological changes in pancreatic remnant after pancreaticoduodenectomy. Pancreas 2007; 35: 361-365.
19. Nakamura H, Murakami Y, Uemura K, et al: Predictive factors for exocrine pancreatic insufficiency after pancreatoduodenectomy with pancreaticogastrostomy. J Gastrointest Surg 2009; 13: 1321-1327.
20. Rault A, SaCunha A, Klopfenstein D, et al: Pancreaticojejunal anastomosis is preferable to pancreaticogastrostomy after pancreaticoduodenectomy for long-term outcomes of pancreatic exocrine function. J Am Coll Surg 2005; 201: 239-244. (Pubitemid 40994958)
21. Sato N, Yamaguchi K, Yokohata K, et al: Short-term and long-term pancreatic exocrine and endocrine functions after pancreatectomy. Dig Dis Sci 1998; 43: 2616-2621. (Pubitemid 29034913)
22. Elphick DA, Kapur K: Comparing the urinary pancrealauryl ratio and faecal elastase-1 as indicators of pancreatic insufficiency in clinical practice. Pancreatology 2005; 5: 196-200. (Pubitemid 40754736)
23. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376. (Pubitemid 23073154)
24. Fayers PM, Hand DJ, Bjordal K, et al: Causal Indicators in quality of life research. Qual Life Res 1997; 6: 139-150. (Pubitemid 27207279)
25. Jones L, Russell C, Mosca F, et al: Standard Kausch-Whipple pancreatoduodenectomy. Dig Surg 1999; 16: 297-304. (Pubitemid 29376331)
26. Pedrazzoli S, Beger H, Obertop H, et al: A Surgical and pathological based classification of resection of pancreatic cancer: Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg 1999; 16: 337-345. (Pubitemid 29376336)
27. Halm U, Loser C, Lohr M, Katschinski M, Mossner J: A double-blind cross-over study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment Pharmacol Ther 1999; 13: 951-957. (Pubitemid 29312782)
28. Van de Kamer JH, ten Bokkel H, Weyers HA: Rapid methods for the determination of fat in feces. J Biol Chem 1949; 177: 347-355.
29. Borowitz D, Lin R, Baker SS: Comparison of monoclonal and polyclonal ELISAs for fecal elastase in patients with cystic fibrosis and pancreatic insufficiency. J Paediatr Gastroenterol Nutr 2007; 44: 219-223. (Pubitemid 46175076)
30. WHO 2004: Definitions of overweight and obesity. http://www.dh.gov.uk/en/ Publichealth/Healthimprovement/Obesity/DH-4133948 (accessed July 20, 2011).
31. Fitzsimmons D, Johnson CD, George S, et al: Development of a disease-specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer 1999; 35: 939-941. (Pubitemid 29277128)
32. EORTC Manuals: Http://groups.eortc.be/qol/documentation-manuals.htm (accessed July 20, 2011).
33. Diener MK, Heukaufer C, Schwarzer G, et al: Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev 2008; 16:CD006053.
34. Lemaire E, O'Toole D, Sauvanet A, et al: Functional and morphological changes in the pancreatic remnant following pancreaticoduodenectomy with pancreaticogastric anastomosis. Br J Surg 2000; 87: 434-438. (Pubitemid 30192952)
35. DiMagno MJ, DiMagno EP: Chronic pancreatitis. Curr Opin Gastroenterol 2006; 22: 487-497. (Pubitemid 44197522)
36. Lankisch PG: Now that fecal elastase is available in the United States, should clinicians start using it? Curr Gastroenterol Rep 2004; 6: 126-131. (Pubitemid 38915059)
37. Lankisch PG, Schmidt I, König H, et al: Faecal elastase-1: Not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut 1998; 42: 551-554. (Pubitemid 28186574)
38. Bachmann J, Heiligensetzer M, Krakowski-Roosen H, et al: Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 2008; 12: 1193-1201.